TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 78 filers reported holding TRINITY BIOTECH PLC in Q1 2016. The put-call ratio across all filers is 5.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $551,000 | -80.7% | 98,132 | -60.0% | 0.01% | -82.8% |
| Q1 2016 | $2,861,000 | -30.3% | 245,330 | -29.7% | 0.06% | -30.1% |
| Q4 2015 | $4,103,000 | -53.3% | 348,935 | -54.5% | 0.08% | -53.9% |
| Q3 2015 | $8,778,000 | -34.8% | 767,299 | +3.0% | 0.18% | -25.6% |
| Q2 2015 | $13,453,000 | -8.7% | 744,930 | -2.7% | 0.24% | -6.2% |
| Q1 2015 | $14,741,000 | +6.7% | 765,753 | -2.9% | 0.26% | +1.6% |
| Q4 2014 | $13,811,000 | +79.5% | 788,769 | +87.3% | 0.25% | +68.2% |
| Q3 2014 | $7,694,000 | -17.3% | 421,136 | +4.2% | 0.15% | -12.7% |
| Q2 2014 | $9,308,000 | -4.4% | 404,182 | +0.6% | 0.17% | -5.5% |
| Q1 2014 | $9,739,000 | -10.0% | 401,942 | -6.6% | 0.18% | -8.5% |
| Q4 2013 | $10,816,000 | +15.5% | 430,218 | -0.0% | 0.20% | +10.5% |
| Q3 2013 | $9,363,000 | +37.0% | 430,265 | +6.1% | 0.18% | +30.2% |
| Q2 2013 | $6,833,000 | – | 405,513 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prospect Capital Advisors, LLC | 336,550 | $3,924,000 | 4.65% |
| ACK Asset Management | 979,600 | $11,422,000 | 4.49% |
| Balter Liquid Alternatives, LLC | 161,284 | $1,881,000 | 4.33% |
| GOLDMAN CAPITAL MANAGEMENT INC | 396,690 | $4,625,000 | 3.50% |
| Paradice Investment Management LLC | 1,435,724 | $16,741,000 | 2.23% |
| Adirondack Research & Management Inc. | 415,353 | $4,843,000 | 1.76% |
| Lapides Asset Management, LLC | 705,100 | $8,221,000 | 1.47% |
| Park West Asset Management LLC | 900,000 | $10,494,000 | 0.99% |
| Benchmark Capital Advisors | 83,541 | $974,000 | 0.86% |
| HEARTLAND ADVISORS INC | 1,290,010 | $15,042,000 | 0.79% |